Brandon Capital

📢 Congratulations to Brandon Capital portfolio company EBR Systems, Inc. on receiving US FDA approval. EBR's WiSE CRT System is designed to overcome the limitations of conventional CRT and is the only leadless left ventricular endocardial pacing device. As covered by The Australian Financial Review, the approval could see them selling their wireless pacing system to prevent heart failure within months – a market that could be worth as much as $6 billion.  Well done to the EBR team led by Chief Executive John McCutcheon and we're proud to be supporting your 'clinical to commercialisation' journey alongside fellow investors M.H. Carnegie & Co., Hostplus and HESTA. https://lnkd.in/ekvUemcS

📢 OncoRes Medical was featured on Nine News last night, highlighting their innovative approach to addressing a critical challenge in breast cancer surgery. As CEO Katharine Giles explained: "𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝘁𝗲𝗰𝗵𝗻𝗶𝗾𝘂𝗲𝘀 𝗹𝗲𝗮𝘃𝗲 𝗮𝗽𝗽𝗿𝗼𝘅𝗶𝗺𝗮𝘁𝗲𝗹𝘆 𝟮𝟬% 𝗼𝗳 𝗯𝗿𝗲𝗮𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗿𝗲𝗾𝘂𝗶𝗿𝗶𝗻𝗴 𝗿𝗲𝗽𝗲𝗮𝘁 𝘀𝘂𝗿𝗴𝗲𝗿𝗶𝗲𝘀. 𝗢𝘂𝗿 𝘀𝘆𝘀𝘁𝗲𝗺 𝗽𝗿𝗼𝘃𝗶𝗱𝗲𝘀 𝗶𝗻𝘁𝗿𝗮𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝘃𝗶𝘀𝘂𝗮𝗹𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗮𝘁 𝗰𝗼𝘂𝗹𝗱 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁𝗹𝘆 𝗿𝗲𝗱𝘂𝗰𝗲 𝘁𝗵𝗶𝘀 𝗻𝘂𝗺𝗯𝗲𝗿." The company's real-time imaging technology helps surgeons identify microscopic tumour margins during breast cancer procedures. ✔️Proprietary micro-elastography platform ✔️FDA Breakthrough Device designation received ✔️Potential applications in multiple cancer types ✔️Anticipated commercialisation within 2.5 years As investors, we recognised OncoRes' potential to address a significant unmet clinical need through their novel imaging approach and are very excited for their future. OncoRes segment available here: https://lnkd.in/gGk-6Us9 (30-minute mark) Follow OncoRes Medical on Linkedin to keep up to date. cc Stephen Thompson Helga Mikkelsen #MedicalTechnology #SurgicalInnovation #HealthcareInvesting

⭐ 𝗣𝗮𝘁𝗵𝗶𝗼𝘀 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁 Congratulations to Dr Sumeet Ambarkhane, MD, who has been appointed Chief Medical Officer of Brandon portfolio company Pathios Therapeutics. With over 20 years of experience in oncology drug development—from early research to regulatory approvals—Sumeet’s expertise will accelerate the clinical advancement of PTT-4256, a first-in-class GPR65 inhibitor with transformative potential in cancer immunotherapy. It's a pivotal moment for Pathios as they pioneer new ways to reprogram the tumour microenvironment. Congratulations to the entire team! #Biotech #ImmunoOncology #VC #FirstInClass

As specialist life sciences investors, Brandon Capital witnesses firsthand the transformative impact of diverse thinking and technical expertise at the board level. So we’re delighted to see events like this one by MinterEllison showcasing how STEM skills can shape the future of governance and innovation, creating vital opportunities for female STEM professionals to transition into board-ready roles. #STEMLeadership #BoardDiversity #WomenInSTEM #InnovationInGovernance

🌟 𝗧𝗵𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗼𝗿𝘀 𝗔𝗺𝗼𝗻𝗴 𝗨𝘀 Proxima Bio is a Melbourne-headquartered biotech developing groundbreaking technology to target and degrade cancer-causing proteins. CSO and co-founder Jase Brouwer, CEO and co-founder Jonathan Bernardini and COO Amanda Woon sat down with us to share their story, which is a timely reminder that founding a company is a team sport. “𝘛𝘩𝘦 𝘬𝘦𝘺 𝘵𝘰 𝘗𝘳𝘰𝘹𝘪𝘮𝘢 𝘉𝘪𝘰’𝘴 𝘴𝘶𝘤𝘤𝘦𝘴𝘴 𝘩𝘢𝘴 𝘣𝘦𝘦𝘯 𝘸𝘰𝘳𝘬𝘪𝘯𝘨 𝘸𝘪𝘵𝘩 𝘵𝘢𝘭𝘦𝘯𝘵𝘦𝘥 𝘪𝘯𝘥𝘪𝘷𝘪𝘥𝘶𝘢𝘭𝘴 𝘸𝘩𝘰 𝘣𝘦𝘭𝘪𝘦𝘷𝘦 𝘪𝘯 𝘰𝘶𝘳 𝘷𝘪𝘴𝘪𝘰𝘯 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘵𝘰 𝘭𝘦𝘷𝘦𝘳𝘢𝘨𝘦 𝘵𝘩𝘦𝘪𝘳 𝘣𝘳𝘰𝘢𝘥 𝘢𝘥𝘷𝘪𝘴𝘰𝘳𝘺 𝘢𝘯𝘥 𝘝𝘊 𝘯𝘦𝘵𝘸𝘰𝘳𝘬𝘴 𝘵𝘰 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘰𝘶𝘳 𝘤𝘩𝘢𝘯𝘤𝘦𝘴 𝘰𝘧 𝘴𝘶𝘤𝘤𝘦𝘴𝘴 𝘢𝘯𝘥 𝘪𝘮𝘱𝘢𝘤𝘵,” 👉 Story here: https://lnkd.in/gNtjBdgc 👉🏾Follow them on LinkedIn: Proxima Bio #TheInnovatorsAmongUs #Biotech #ScienceStories #Innovation #Resilience #ProximaBio

🌟 𝗧𝗵𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗼𝗿𝘀 𝗔𝗺𝗼𝗻𝗴 𝗨𝘀 At Brandon, we’re fortunate to have a front-row seat—and a backstage pass—to some groundbreaking companies and the people behind them. These stories are not only fascinating but also rich with insights, so we’re experimenting with a new platform to share them. 𝗧𝗵𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗼𝗿𝘀 𝗔𝗺𝗼𝗻𝗴 𝗨𝘀 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄 with Proxima Bio, a Melbourne-headquartered biotech company redefining how cancer could be treated. It's a story forged from academic expertise, entrepreneurial vision, and global experience, so please keep a lookout for it in your feeds. Then, each month until the end of the year, we'll release a new story from our network, and if you find it valuable, we’ll make the series permanent. #Biotech #HealthcareInnovation #ProximaBio #BrandonBioCatalyst #CUREator #MedicalResearch

🎟️Second up in our Biotech Entrepreneurs In SA Series is Brandon Capital Venture Partner Tom McCarthy. Tom will be sharing his extensive biotech entrepreneurial journey, which includes Pathios Therapeutics and Spinifex Pharmaceuticals Inc., among others. RSVP link to join Tom and our partner Melissa McBurnie 👇🏿

🚀OncoRes is determined to rewrite the narrative for the 𝟭 𝗶𝗻 𝟰 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 who currently require repeat operations due to missed cancerous tissue after undergoing 𝗯𝗿𝗲𝗮𝘀𝘁-𝗰𝗼𝗻𝘀𝗲𝗿𝘃𝗶𝗻𝗴 𝘀𝘂𝗿𝗴𝗲𝗿𝘆. Thank you to Louise Weihart from Mergermarket, who sat down with OncoRes CEO Katharine Giles to cover what the company has been up to. 🔷 Successfully completed multi-site trials for its first-of-its-kind handheld imaging system, Elora, involving over 240 breast cancer patients in Australia. 🔷 Elora’s imaging platform has broad applicability across solid cancer surgeries, including minimally invasive and robotic techniques. 🔷 Technology empowers surgeons to identify and remove all cancerous tissue in a single operation, addressing a critical unmet need. 🔷 Designed collaboratively by engineers, surgeons, and pathologists, Elora has garnered global enthusiasm from medical professionals eager to see it in the market. Link to Mergermarkets in the comments. Stephen Thompson Helga Mikkelsen #OncoRes #BrandonCapital #CancerInnovation #MedTech #Healthcare #SurgicalInnovation #BreastCancerAwareness

Celebrating the Women Science Almost Didn’t See Imagine a world where some of the brilliant minds behind the structure of DNA, the understanding of radioactivity, or the calculations that helped send humanity to the moon were never given the chance to contribute. We risk this imagined world becoming a reality when underrepresented communities, including women, opt out of science, are denied opportunities to contribute, or lack the supportive cultures needed to thrive in scientific inquiry. To acknowledge International Women’s Day on Saturday, we shared Women in Science: 50 Fearless Pioneers Who Changed the World by Rachel Ignotofsky with a personal message from one of our incredible women scientists. By sharing this book with Brandon BioCatalyst members, we hope to inspire girls and boys to pursue STEM, showing that science is for everyone—because when the world loses even one voice, idea, or breakthrough, we’re all poorer for it.  #InternationalWomensDay #WomenInSTEM #YouCantBeWhatYouCantSee #WomenInScience #BrandonCapital #DiversityInScience

Are you, or do you know a Radiochemist? Advancell is hiring! They recently raised over USD 112 million, signed a partnership with Eli Likly and have an incredible leadership team so it’s worth a look and/or a share.